期刊文献+

植入式心脏起搏器囊袋切口缝合方式对比研究 被引量:3

下载PDF
导出
摘要 目的:探讨起搏器植入术中2种不同切口缝合方法对患者术后恢复的影响。方法:2011年1月—2016年1月于苏北人民医院心血管内科接受首次埋藏式心脏起搏器治疗的822例患者,按拟行切口缝合方式不同随机分为2组:A组412例采用医用皮肤表面缝合器拉合法:包括单腔起搏器86例,双腔起搏器268例,植入型心律转复除颤器(ICD)19例,心脏再同步化治疗起搏器/除颤器(CRT/D)39例;B组410例,使用连续皮内缝合,包括单腔起搏器82例,双腔起搏器271例,ICD 22例,CRT/D35例。结果:两组患者性别、年龄、伴随疾病(高血压、冠心病、糖尿病等)及抗凝/抗血小板药物使用差异无统计学意义。A组缝合时间明显短于B组[(3.6±1.5)min vs.(5.1±1.8)min,P<0.001];A组术后住院时间明显短于B组[(5.16±0.56)d vs.(6.18±0.39)d,P<0.001)];A组术后囊袋压迫时间明显短于B组[(6.5±1.8)h vs.(8.7±2.0)h,P<0.001)];所有患者术后共有31例囊袋血肿,A组明显少于B组(2.42%vs.5.12%,P<0.05);所有患者均Ⅰ期甲级愈合,55例患者切口瘢痕较大,A组明显少于B组(4.37%vs.9.02%,P<0.05)。结论:采用皮肤表面缝合器拉合法明显缩短切口缝合时间和患者住院时间,降低囊袋血肿和切口瘢痕的发生率,适合临床上推广。
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2018年第4期518-520,555,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省临床医学专项基金(BL2013022)
  • 相关文献

参考文献7

二级参考文献74

  • 1俞宙,丁力,梁化达.经皮冠状动脉介入治疗术后近期行永久起搏器治疗的安全性探讨[J].中国心脏起搏与心电生理杂志,2004,18(5):350-351. 被引量:2
  • 2曹万才,王可富,周聊生,徐庆国,李爱国,黄明慧,张奇志,李丕宝.老年起搏器囊袋血肿原因分析及临床对策[J].中华老年心脑血管病杂志,2007,9(8):567-567. 被引量:11
  • 3Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the manage- ment of valvular heart disease:The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J ,2007,28:230-268.
  • 4Carom AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrilla- tion of the European Society of Cardiology(ESC). Eur Heart J ,2010, 31:2369-2429.
  • 5Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease:a report of the American College of Cardiology/Ameriean Heart Association Task Force on Practice Guidelines ( writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Dis- ease) : developed in collabon~tion with the Society of Cardiovascular Anesthesiologists:endorsed by the Society for Cardiovascular Angiogra- phy and Interventions and the Society of Thoracic Surgeons. Cireula- tion ,2006,114 : e84-231.
  • 6Fleisber LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperafive beta blockade incorporated into the ACC/ AHA 2007 guidelines on periopemtive cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardio1,2009,54:e13-e1 18.
  • 7Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma af- ter pacemaker or implantable cardioverter defibrillator surgery : influ- ence of patient morbidity, operation strategy, and pefioperative anti- platelet/anticoagulation therapy. Chest, 2004,126 : 1177 -1186.
  • 8Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators :results of a large prospective study. Circulation,2007,116 : 1349-1355.
  • 9Miehaud GF, Pelosi F, Noble MD, et al. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implanta- tion. J Am Coil Cardio1,2000,35 : 1915-1918.
  • 10Cheng A, Nazarian S, Brinker JA, et al. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation : a ran- domized clinical trial. Heart Rhythm ,2011,8:536-540.

共引文献17

同被引文献23

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部